A simple gel applied to the gums of babies at risk of hypoglycaemia may protect them from developing the life-threatening condition, according to Liggins Institute researchers. A three-year trial funded by Cure Kids is being undertaken by researchers at the University of Auckland’s Liggins Institute and Starship Hospital. The project, due to start in May, involves a number of Gravida members, along with a Gravida-funded clinical PhD student.
If the trial finds the gel can prevent babies developing hypoglycaemia, it could be used as a standard treatment for at-risk babies, and do away with the need for painful blood tests.
Read more here in or here on the Cure Kids website.